Participants treated with Tirzepatide experienced an average weight loss of 15% to 20% of their initial body weight over the course of 72 weeks (approximately 16.5 months), which translated to an average weight loss of 34 lbs
In fact, people with obesity have a 55% higher chance of developing depression, while people diagnosed with depression have a 58% higher chance of developing obesity, according to a study from 2020
This keeps comparison clear and avoids unsupported claims
This is more comprehensive than some competitors that charge extra for these services or do not offer them at all
Other potential benefits include enhanced blood-glucose management, improvements in cardiovascular health, reductions in inflammation, and possibly even liver support for those with non-alcoholic fatty liver disease
Convenience often plays a major role in long-term results, and a nearby medical clinic can make the process more manageable